USFDA to soon authorize Pfizer COVID booster shot for children aged 5 to 11: NYT Ruchika Sharma17 May 2022 11:00 AM ISTThey have cited data from a mid- to late-stage study showing a third dose of their shot increased protection against the original coronavirus version...
COVID vaccine makers shift focus to booster shots Ruchika Sharma10 May 2022 11:00 AM ISTPfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...
BioNTech posts tripled Q1 vaccine sales but still flags full-year decline Ruchika Sharma10 May 2022 9:15 AM ISTBioNTech reiterated its 2022 vaccine revenue guidance of between 13 billion and 17 billion euros, down from 19 billion last year, implying a decline...
Pfizer keeps coronavirus sales forecast unchanged as pandemic curbs ease Ruchika Sharma5 May 2022 10:00 AM ISTThe company's reluctance to lift that forecast could signal a dearth of new sales contracts for the drug during the first quarter.
Pfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 years Ruchika Sharma28 April 2022 3:22 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (USFDA) for Emergency Use Authorization...
Pfizer to seek USFDA nod for COVID booster for healthy 5- to 11-year-olds Ruchika Sharma17 April 2022 9:45 AM ISTThe Pfizer shots are the only vaccine available to US children.
BioNTech COVID vaccine causes deafness: WHO Isra Zaman5 April 2022 2:58 PM ISTAccording to a VigiBase report from WHO, instances of auditory loss also referred to as tinnitus was observed in people who were given Covid-19...
BioNTech to expand clinical trial programme for more anti-Omicron vaccine options MD Bureau31 March 2022 4:53 PM ISTBioNTech said on Wednesday it would expand an ongoing clinical trial programme to develop new vaccines and patterns of administration for better...
Pfizer gets expanded USFDA emergency use nod for additional COVID Vaccine booster in adults aged 50 years and older Ruchika Sharma30 March 2022 12:25 PM ISTThe additional booster is to be administered at least four months after the first booster and is the same formulation and strength as prior...
Moderna to set RNA vaccine manufacturing facility in Kenya MD Bureau9 March 2022 1:01 PM ISTModerna said it expects to invest about $500 million in the Kenyan facility and supply as many as 500 million doses of mRNA vaccines to the continent...
US FDA considers approving a second Covid-19 booster shot: Report MD Bureau21 Feb 2022 9:00 AM ISTNew Delhi: US health regulators are looking at authorizing a potential fourth dose of a Covid-19 vaccine in the fall, the Wall Street Journal reported...
BioNTech- Pfizer Omicron vaccine delayed, says BioNTech Chief Ugur Sahin Ruchika Sharma17 Feb 2022 3:25 PM ISTBerlin: Delivery of Pfizer and BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than...
